论文信息 - A phase III randomized trial of two different dosing schedules of erythropoietin (EPO) in patients with cancer-associated anemia: North Central Cancer Treatment Group (NCCTG) Study N02C2 - 字舞流文

A phase III randomized trial of two different dosing schedules of erythropoietin (EPO) in patients with cancer-associated anemia: North Central Cancer Treatment Group (NCCTG) Study N02C2

P. Novotny | J. Sloan | C. Loprinzi | K. Rowland | D. Steensma | T. Dentchev | P. Schaefer | D. Nikcevich | L. Tschetter | R. Molina